Mayne Pharma directly markets more than 60 products in the US including four brandeddermatology products FABIOR® (tazarotene) Foam, SORILUX (calcipotriene) Foam, DORYX® MPC(doxycycline hyclate) delayed-release tablets and LEXETTE (halobetasol propionate) Foam. TheCompany recently received approval for TOLSURA™ (SUBA®-itraconazole) capsules used to treatcertain fungal infections which it also recently launched. SHIVERS. What the fH ck. 60 products marketed directly in USA. 100 MILLION EACH IS 6 BILLION usd. 50 million each is 3 billion USD = 4.2 BILLION AUD. Forget the rest. what is happening here folks stock selling at 85 cents. I can 't understand it. It is future Blakmores of generics or CSL whatecver U want to call it. I am not changing my opinion.
MYX Price at posting:
85.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)